NCT02947386 2023-10-05Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung CancerRoswell Park Cancer InstitutePhase 1 Completed7 enrolled
NCT00950417 2015-08-19Nimotuzumab in Combination With Chemoradiation for Esophageal CancerBiotech Pharmaceutical Co., Ltd.Phase 1 Completed11 enrolled
NCT00369252 2007-02-28Phase I Study of Nimotuzumab in Solid TumoursYM BioSciencesPhase 1 Completed18 enrolled